Liu Y., Hu X., Shan X., Chen K., Tang H.（汤华） (2019) Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway. Cancer Cell Int 19: 13.（肝研所）（IF: 2.74）
Yang Q. X., Zhong S., He L., Jia X. J., Tang H., Cheng S. T., Ren J. H., Yu H. B., Zhou L., Zhou H. Z., Ren F., Hu Z. W., Gong R., Huang A. L., Chen J.（陈娟） (2019) PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway. Cancer Lett 452: 90-102.（肝研所）（IF: 6.375）
Li W. Y., Zhou H. Z., Chen Y., Cai X. F., Tang H., Ren J. H., Wai Wong V. K., Kwan Law B. Y., Chen Y., Cheng S. T., Yu H. B., Cai H. Y., Chen W. X., Tang N., Zhang W. L., Tao N. N., Yang Q. X., Ren F., He L., Jiang H., Huang A. L., Chen J.（陈娟） (2019) NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein. Cancer Lett 451: 156-167. （肝研所）（IF: 6.375）
Yan L., Xiong C., Xu P., Zhu J., Yang Z., Ren H., Luo Q. （罗强）(2019) Structural characterization and in vitro antitumor activity of A polysaccharide from Artemisia annua L. (Huang Huahao). Carbohydr Polym 213: 361-369.（肝研所）（IF: 4.811）
Chang Y., Li H., Ren H., Xu H., Hu P.（胡鹏） (2019) Misclassification of chronic hepatitis B natural history phase: Insight from new ALT, AST, AKP, and GGT reference intervals in Chinese children. Clin Chim Acta 489: 61-67.（肝研所）（IF: 2.873）
Li C., Zhou D., Jiang X., Liu M., Tang H.（汤华）, Mei Z.（梅浙川） (2019) Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Gene 698: 9-18.（肝研所）（IF: 2.415）
Li Y., Yang P., Zhao L., Chen Y., Zhang X., Zeng S., Wei L., Varghese Z., Moorhead J. F., Chen Y.（陈压西）, Ruan X. Z.（阮雄中） (2019) CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway. J Lipid Res 60: 844-855.（肝研所）（IF: 4.81）
Ling J., Zhao M., Chen F., Zhou X., Li X., Ding S., Tang H.（汤华） (2019) An enzyme-free electrochemiluminescence biosensor for ultrasensitive assay of Group B Streptococci based on self-enhanced luminol complex functionalized CuMn-CeO2 nanospheres. Biosens Bioelectron 127: 167-173.（肝研所）（IF: 7.78）
Li D., Chen A., Lan T., Zou Y., Zhao L., Yang P., Qu H., Wei L., Varghese Z., Moorhead J. F., Chen Y.（陈压西）, Ruan X. Z.（阮雄中） (2019) SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE(-/-) mice. Faseb j 33: 3437-3450.（肝研所）（IF: 5.498）
Chen X., Hu Y., Zhang W., Chen K., Hu J., Li X., Liang L., Cai X., Hu J., Wang K.（*）, Huang A.（黄爱龙）, Tang N.（唐霓） (2019) Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway. Free Radic Biol Med 131: 225-236.（肝研所）（IF: 5.606）
Shu F., Zou X., Tuo H., She S., Huang J., Ren H., Hu H., Peng S., Wang J.（*）, Yang Y.(杨轶轩) (2019) Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling. Int J Oncol 54: 1086-1098.（肝研所）（IF: 3.079）
Tuo L., Xiang J., Pan X., Hu J., Tang H., Liang L., Xia J., Hu Y., Zhang W., Huang A.（黄爱龙）, Wang K.（*）, Tang N.（唐霓） (2019) PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27(Kip1) axis. J Exp Clin Cancer Res 38: 50.（肝研所）（IF: 6.217）
Zhang X., Yang P., Luo X., Su C., Chen Y., Zhao L., Wei L., Zeng H., Varghese Z., Moorhead J. F., Ruan X. Z.（阮雄中）, Chen Y.（陈压西） (2019) High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways. Lipids Health Dis 18: 76.（肝研所）（IF: 2.073）
Cai D., Pan C., Yu W., Dang S., Li J., Wu S., Jiang N., Wang M., Zhang Z., Lin F., Xin S., Yang Y., Shen B., Ren H.（任红） (2019) Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive HBeAg-positive patients with chronic hepatitis B: A large, multicentre, randomized controlled trials. Medicine (Baltimore) 98: e13983.（肝研所）（IF: 1.803）
Zhan Z., Chen Y., Duan Y., Li L., Mew K., Hu P., Ren H., Peng M.（彭明利） (2019) Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis. PeerJ 7: e6645.（肝研所）（IF: 2.177）
Liu Y., Wang D., Li Y., Yan S., Dang H., Yue H., Ling J., Chen F., Zhao Y., Gou L., Tang P., Huang A., Tang H.（汤华） (2019) Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1. Exp Cell Res.（肝研所）（IF: 3.546）
Zhou L., Ren J. H., Cheng S. T., Xu H. M., Chen W. X., Chen D. P., Wong V. K. W., Law B. Y. K., Liu Y., Cai X. F., Tang H., Yu H. B., Hu J. L., Hu Y., Zhou H. Z., Ren F., He L., Hu Z. W., Jiang H., Xu H. Y., Huang A. L.（黄爱龙）, Chen J.（陈娟） (2019) A Functional Variant in Ubiquitin Conjugating Enzyme E2 L3 Contributes to Hepatitis B Virus Infection and Maintains Covalently Closed Circular DNA Stability by Inducing Degradation of Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit 3A. Hepatology.（肝研所）（IF: 13.246）
Cai Y., Liu D., Cui J., Sha Y., Zhou H., Tang N., Wang N.（王娜）, Huang A., Xia J.（夏杰） (2019) Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis. Medicine (Baltimore) 98: e15096.（肝研所）（IF: 1.803）
Luo A., Xu P., Wang J., Li Z., Wang S., Jiang X., Ren H., Luo Q.（罗强） (2019) Efficacy and safety of direct-acting antiviral therapy for chronic hepatitis C genotype 6: A meta-analysis. Medicine (Baltimore) 98: e15626.（肝研所）
Shen Y., Pan Z., Zhang L., Xue W., Peng M., Hu P., Xu H.（*）, Chen M.（陈敏） (2019) Increased effector gammadelta T cells with enhanced cytokine production are associated with inflammatory abnormalities in severe hand, foot, and mouth disease. Int Immunopharmacol 73: 172-180.（肝研所）（IF: 2.956）
Xue W., Liu K., Qiu K., Shen Y., Pan Z., Hu P., Peng M., Chen M.（陈敏）, Ren H.（任红） (2019) A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation? Int J Infect Dis 83: 56-63.（肝研所）（IF: 2.532）
Yang F., Li J., Deng H., Wang Y., Lei C., Wang Q., Xiang J., Liang L., Xia J., Pan X., Li X., Long Q., Chang L., Xu P., Huang A.（黄爱龙）, Wang K.（汪凯）, Tang N.（唐霓） (2019) GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone. Embo j: e101964.（肝研所）（IF: 9.792）
Zhang Q. Y., Zhang Q. F., Zhang D. Z.(张大志) (2019) The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis. Biomed Res Int 2019: 3962785.（肝研所）（IF: 2.476）
Long Q., Xiang X., Yin Q., Li S., Yang W., Sun H., Liu Q., Xie J.（*）, Deng W.（邓万燕） (2019) PE_PGRS62 promotes the survival of Mycobacterium smegmatis within macrophages via disrupting ER stress-mediated apoptosis. J Cell Physiol.（肝研所）（IF: 4.08）
Yu G., Xiong D., Liu Z., Li Y., Chen K., Tang H.（汤华） (2019) Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression. J Cell Biochem.（肝研所）（IF: 3.085）
Qingzhu Gao, Guiji Zhang, Yaqiu Zheng, Yi Yang, Chang Chen, Jie Xia, Li Liang, Chong Lei, Yuan Hu, Xuefei Cai, Wenlu Zhang, Hua Tang, Yaxi Chen（陈亚西）, Ailong Huang（黄爱龙）, Kai Wang（汪凯） & Ni Tang（唐霓） (2019). "SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC." Cell Death & Differentiation.(肝研所)(IF:8.086)
Ting Hu,Hang Sun（孙航）,Wan-Yan Deng（邓万燕）,Wen-Qi Huang,Qi Liu（刘杞） (2019). Augmenter of Liver Regeneration Protects Against Acetaminophen-Induced Acute Liver Injury in Mice by Promoting Autophagy.Shock 52(2): 274-283.（肝研所）(IF:3.083)
Chuanfei Li（李传飞） , Di Zhou , Hao Hong , Shuangyan Yang , Li Zhang , Shiying Li , Peng Hu（胡鹏） , Hong Ren（任红） , Zhechuan Mei （梅浙川） , Hui Tang（汤慧） (2019). "TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma." Aging (Albany NY) 11(15): 5593-5612.（肝研所）(IF:4.398)
Ren, H.（任红） (2019). "On the way towards the eradication of chronic hepatitis B." J Viral Hepat 26 Suppl 1: 3-4.（肝研所）(IF:4.016)
Ren, H. （任红）and Y. Huang (2019). "Effects of pegylated interferon-alpha based therapies on functional cure and the risk of hepatocellular carcinoma development in patients with chronic hepatitis B." J Viral Hepat 26 Suppl 1: 5-31.（肝研所）(IF:4.016)
Lei C, Wang Q, Tang N（唐霓）, Wang K（汪凯）. GSTZ1-1 downregulates Wnt/β-catenin signalling in hepatocellular carcinoma cells. FEBS Open Bio. 2019 Nov 28. doi: 10.1002/2211-5463.12769. [Epub ahead of print] (IF 1.959，共同通讯作者)
Zhou X, Zhao L, Yang P, Chen Y*（陈压西）, Ruan XZ（阮雄中）*. The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis. Gastroenterol Res Pract. 2019 Feb;2019:3480732（IF=1.825）
Wang J, Qu B, Zhang F, Zhang C, Deng W（邓万燕）, Dao Thi VL, Xia Y. Stem Cell-Derived Hepatocyte-Like Cells as Model for Viral Hepatitis Research. Stem Cells Int. 2019 Jun 12;2019:9605252.